Clinical Epidemiology of Chronic Liver Diseases
-15%
portes grátis
Clinical Epidemiology of Chronic Liver Diseases
Gish, Robert G.; Wong, Robert J.
Springer International Publishing AG
11/2018
349
Dura
Inglês
9783319943541
15 a 20 dias
855
Descrição não disponível.
Introduction - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Principles of Clinical Epidemiology - Jerry Gardner, Science for Organizations
Understanding Study Design for Clinical Epidemiology Studies - Irene Yen, University of California, San Francisco
Understanding the Interpretation of Disease Incidence and Prevalence - Sarah Larney, National Drug and Alcohol Research Center, Australia
Understanding Survival Analyses - Jerry Gardner, Science for Organizations
Epidemiology of Liver Disease - Worldwide Perspective - Nimzing Ladep, Imperial College London and Mamun Al-Mahtab, Bangabandhu Sheikh Mujib Medical University
Epidemiology of Liver Disease in the U.S. - Michael Volk, Loma Linda
Alcoholic Liver Disease - Ashwani Singal, University of Alabama
Hepatitis B Virus - The Asian Perspective - Man-Fung Yuen, University of Hong Kong
Hepatitis B Virus - The African Perspective - Ramou Njie, MRC Unit Gambia
Hepatitis B Virus - Western Perspective - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Hepatitis D Virus - Mario Rizzetto, University of Torino, Molinette Hospital
Hepatitis C Virus - Joseph Lim, Yale University and Imam Waked, National Liver Institute Egypt
Hepatitis A and Hepatitis E Virus - Mohammad Sultan Khuroo, Kashmir, India and Elisabetta Franco, Rome, Italy
Nonalcoholic Fatty Liver Disease - Edward Holt, California Pacific Medical Center
Hepatocellular Carcinoma - Hashem El-Serag, Baylor Medical Center, Houston
Autoimmune Liver Diseases and Cholestatic Liver Diseases - Michael Manns, Hannover Medical School, Germany
Genetic and Inherited Liver Diseases - Kris Kowdley, University of Washington
Cryptogenic Liver Diseases and other - Peter Bypass, University of Aberdeen
Summary - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Principles of Clinical Epidemiology - Jerry Gardner, Science for Organizations
Understanding Study Design for Clinical Epidemiology Studies - Irene Yen, University of California, San Francisco
Understanding the Interpretation of Disease Incidence and Prevalence - Sarah Larney, National Drug and Alcohol Research Center, Australia
Understanding Survival Analyses - Jerry Gardner, Science for Organizations
Epidemiology of Liver Disease - Worldwide Perspective - Nimzing Ladep, Imperial College London and Mamun Al-Mahtab, Bangabandhu Sheikh Mujib Medical University
Epidemiology of Liver Disease in the U.S. - Michael Volk, Loma Linda
Alcoholic Liver Disease - Ashwani Singal, University of Alabama
Hepatitis B Virus - The Asian Perspective - Man-Fung Yuen, University of Hong Kong
Hepatitis B Virus - The African Perspective - Ramou Njie, MRC Unit Gambia
Hepatitis B Virus - Western Perspective - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Hepatitis D Virus - Mario Rizzetto, University of Torino, Molinette Hospital
Hepatitis C Virus - Joseph Lim, Yale University and Imam Waked, National Liver Institute Egypt
Hepatitis A and Hepatitis E Virus - Mohammad Sultan Khuroo, Kashmir, India and Elisabetta Franco, Rome, Italy
Nonalcoholic Fatty Liver Disease - Edward Holt, California Pacific Medical Center
Hepatocellular Carcinoma - Hashem El-Serag, Baylor Medical Center, Houston
Autoimmune Liver Diseases and Cholestatic Liver Diseases - Michael Manns, Hannover Medical School, Germany
Genetic and Inherited Liver Diseases - Kris Kowdley, University of Washington
Cryptogenic Liver Diseases and other - Peter Bypass, University of Aberdeen
Summary - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Hepatitis B Virus;Hepatitis C Virus;Non-alcoholic Fatty Liver Disease;Alcoholic Fatty Liver Disease;Hepatocellular Carcinoma;case-control study;cohort study;incidence;prevalence;survival analysis;Alcoholic cirrhosis;liver cancer;biliary cholangitis;sclerosing cholangitis;hepatology;pharmacoeconomics
Introduction - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Principles of Clinical Epidemiology - Jerry Gardner, Science for Organizations
Understanding Study Design for Clinical Epidemiology Studies - Irene Yen, University of California, San Francisco
Understanding the Interpretation of Disease Incidence and Prevalence - Sarah Larney, National Drug and Alcohol Research Center, Australia
Understanding Survival Analyses - Jerry Gardner, Science for Organizations
Epidemiology of Liver Disease - Worldwide Perspective - Nimzing Ladep, Imperial College London and Mamun Al-Mahtab, Bangabandhu Sheikh Mujib Medical University
Epidemiology of Liver Disease in the U.S. - Michael Volk, Loma Linda
Alcoholic Liver Disease - Ashwani Singal, University of Alabama
Hepatitis B Virus - The Asian Perspective - Man-Fung Yuen, University of Hong Kong
Hepatitis B Virus - The African Perspective - Ramou Njie, MRC Unit Gambia
Hepatitis B Virus - Western Perspective - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Hepatitis D Virus - Mario Rizzetto, University of Torino, Molinette Hospital
Hepatitis C Virus - Joseph Lim, Yale University and Imam Waked, National Liver Institute Egypt
Hepatitis A and Hepatitis E Virus - Mohammad Sultan Khuroo, Kashmir, India and Elisabetta Franco, Rome, Italy
Nonalcoholic Fatty Liver Disease - Edward Holt, California Pacific Medical Center
Hepatocellular Carcinoma - Hashem El-Serag, Baylor Medical Center, Houston
Autoimmune Liver Diseases and Cholestatic Liver Diseases - Michael Manns, Hannover Medical School, Germany
Genetic and Inherited Liver Diseases - Kris Kowdley, University of Washington
Cryptogenic Liver Diseases and other - Peter Bypass, University of Aberdeen
Summary - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Principles of Clinical Epidemiology - Jerry Gardner, Science for Organizations
Understanding Study Design for Clinical Epidemiology Studies - Irene Yen, University of California, San Francisco
Understanding the Interpretation of Disease Incidence and Prevalence - Sarah Larney, National Drug and Alcohol Research Center, Australia
Understanding Survival Analyses - Jerry Gardner, Science for Organizations
Epidemiology of Liver Disease - Worldwide Perspective - Nimzing Ladep, Imperial College London and Mamun Al-Mahtab, Bangabandhu Sheikh Mujib Medical University
Epidemiology of Liver Disease in the U.S. - Michael Volk, Loma Linda
Alcoholic Liver Disease - Ashwani Singal, University of Alabama
Hepatitis B Virus - The Asian Perspective - Man-Fung Yuen, University of Hong Kong
Hepatitis B Virus - The African Perspective - Ramou Njie, MRC Unit Gambia
Hepatitis B Virus - Western Perspective - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Hepatitis D Virus - Mario Rizzetto, University of Torino, Molinette Hospital
Hepatitis C Virus - Joseph Lim, Yale University and Imam Waked, National Liver Institute Egypt
Hepatitis A and Hepatitis E Virus - Mohammad Sultan Khuroo, Kashmir, India and Elisabetta Franco, Rome, Italy
Nonalcoholic Fatty Liver Disease - Edward Holt, California Pacific Medical Center
Hepatocellular Carcinoma - Hashem El-Serag, Baylor Medical Center, Houston
Autoimmune Liver Diseases and Cholestatic Liver Diseases - Michael Manns, Hannover Medical School, Germany
Genetic and Inherited Liver Diseases - Kris Kowdley, University of Washington
Cryptogenic Liver Diseases and other - Peter Bypass, University of Aberdeen
Summary - Robert Wong, Alameda Health System and Robert Gish, Stanford University
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Hepatitis B Virus;Hepatitis C Virus;Non-alcoholic Fatty Liver Disease;Alcoholic Fatty Liver Disease;Hepatocellular Carcinoma;case-control study;cohort study;incidence;prevalence;survival analysis;Alcoholic cirrhosis;liver cancer;biliary cholangitis;sclerosing cholangitis;hepatology;pharmacoeconomics
